About Ophthalmology


In Ophthalmology we are researching and developing innovative treatments for people living with a range of eye diseases that cause significant visual impairment and blindness.  

Our ophthalmic research programs are focused on addressing the leading causes of blindness, including neovascular age-related macular degeneration (AMD), diabetic macular edema, glaucoma, geographic atrophy secondary to AMD and other retinal diseases.

Together with our work in developing new formulations and sustained ophthalmic delivery devices which help to efficiently and conveniently deliver the benefits of treatment, we are committed to helping improve the quality of life for people living with devastating eye conditions.